跳至主要内容
临床试验/DRKS00027852
DRKS00027852已完成不适用

Study of the use of autologous platelet concentrate during pars-plana-vitrectomy for epiretinal gliosis and impending macular hole - ATHENA

GWT TUD GmbH0 个研究点目标入组 57 人开始时间: 2022年1月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
GWT TUD GmbH
入组人数
57

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age = 18 years
  • Patients with epiretinal gliosis and BCVA = 35 (according to ETDRS).
  • Written informed consent to participate in the study
  • Presence of an artificial intraocular lens
  • Ability to donate autologous platelets

排除标准

  • Patients with own lens
  • Treatment with intravitreal injections in the previous 3 months in the study eye
  • Pathological changes of the anterior segment of the eye affecting BCVA (corneal opacities or similar)
  • Acute inflammation in the study eye
  • advanced glaucoma with optic atrophy and central visual field defects in the study eye
  • wet form of age-related macular degeneration as well as advanced form of dry age-related macular degeneration (geographic atrophy)
  • presence of pregnancy

研究者

发起方
GWT TUD GmbH

相似试验